
    
      The study include:

      200 knees, 50 knees will have single injection of Crespine gel, and 50 knees will have single
      injection of 2 ampules of Intragel, also 50 knees will have single injection of Crespine plus
      gel and 50 knees will have single injection of Monovisc The patient will be randomized to
      Crespine gel or to Intragel, and Crespine Plus gel or to Monovisc

      Inclusion Criteria: patients with Osteoarthritis grade II and III according to Kellgren and
      Lawrence grading were included.

      Exclusion Criteria: patients with autoimmune illnesses, active inflammation or infected
      processes, anticoagulant, and known allergy to hyaluronic acid.

      Target parameters:

        -  Lower extremity functional scale

        -  Visual analogue scale

        -  Range of motion

        -  Kellgren and Lawrence class grade

      Eligibility:

      Ages Eligible for Study: 20 years to 70 years Genders Eligible for Study: both Accepts
      Healthy Volunteers: no

      Criteria

      Inclusion Criteria:

        -  Age of patients between 20 and 70 years

        -  patients with Osteoarthritis grade II and III according to Kellgren and Lawrence grading

      Exclusion Criteria:

        -  Autoimmune illnesses

        -  Active inflammation or infected processes

        -  Anticoagulant

        -  Known allergy to hyaluronic acid.
    
  